Me-CCNU

DRUG2 trials

Sponsors

First Affiliated Hospital of Zhejiang University, Yi Luo

Conditions

Graft-versus-host-diseaseLeukemiaMDS

Phase 2

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Yi LuoGraft-versus-host-disease, Leukemia

Start: 2020-12-03End: 2024-12-31Target: 46Updated: 2023-02-21

Phase 3

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Active, not recruitingNCT04547049

First Affiliated Hospital of Zhejiang UniversityLeukemia, MDS

Start: 2020-09-01End: 2026-04-01Target: 232Updated: 2026-04-09